Linguistic Validation, Cognitive Debriefing & Clinician Review
- From Someone Who’s Done Both Sides of the Table
26 years of specialist medical translation. A background in clinical research. The expertise to take your PRO instruments from source to submission-ready – without handoffs, delays or surprises.
Your PRO data is only as reliable as your patients’ comprehension. Regulatory agencies know this. So do you.
The problem isn’t finding a translation vendor. It’s finding one who understands the clinical context behind every item on your instrument - and can defend every linguistic decision in a regulatory audit.
That’s what We offer
Linguistic Validation
Full-cycle LV for PROs, COAs, eCOAs and QoL instruments. Forward translation, back-translation, reconciliation, cognitive debriefing and final harmonisation report – all delivered in compliance with FDA, EMA and ISPOR guidelines. Every project includes a complete audit trail and submission-ready documentation.
We can handle 100+ working languages
Cognitive Debriefing
Structured participant interviews conducted by an experienced clinical researcher – not outsourced to a pool of freelancers unfamiliar with your protocol. We identify comprehension gaps, cultural equivalence issues and item-level ambiguities, then deliver a linguistic validation report your regulatory team can use directly.
Clinician Review
Medical review of translated instruments by a trained clinician with direct experience in clinical trial environments. We check terminology accuracy, clinical plausibility and patient- population suitability – the review layer that separates a defensible submission from a vulnerable one.
The Talkaboutable Edge (Differentiator)
Every engagement delivers:
- Forward and back-translation reports
- Cognitive debriefing transcripts and summary tables
- Reconciliation notes with rationale
- Clinician review commentary
- Harmonisation summary
- Final LV report with full audit trail
Documentation follows current best practice for FDA, EMA and ISPOR submissions.
Works Well For
- Phase II–IV clinical trials
- PRO and eCOA validation
- Medical device instructions for use
- Health economics instruments
- Regulatory submissions requiring LV
Let’s talk about your study.
We’ll review your instrument, confirm scope and give you a clear timeline and quote within 48 hours.
